期刊文献+

慢性肾脏病3~5期患者血清全段甲状旁腺激素与左室肥厚和功能的关系 被引量:1

下载PDF
导出
摘要 目的探讨慢性肾脏病(CKD)3~5期患者血清全段甲状旁腺激素(iPTH)的变化与左室肥厚和功能的关系。方法分别将C K D 3~5期患者按期分为B、C、D三组,选择同期健康体检者设为A组进行对照,检测其血清i P T H水平,左心室情况及血流速度,分析其心脏结构与功能改变与i P T H的关系。结果 C K D患者血清钙、血红蛋白(H G B)、红细胞压积(H C T)、射血分数(E F)、舒张早期和晚期最大血流速度比(E/A)水平均随肾功能不全的进展呈下降趋势,其中HGB、HCT比较显著。血清磷、血肌酐(Scr)、尿素氮(BUN)、iPTH、左心室心肌重量(LVM)、左室心肌重量指数(L V M I)水平随分期的进展呈上升趋势,其中S c r、B U N、L V M、LVMI比较显著。i P T H与BUN、S c r、血清磷、L V M、L V M I呈正相关,与肾小球滤过率(G F R)、H G B、血清钙离子、E/A呈负相关,与E F无相关关系。结论从慢性肾功能不全早期开始纠正患者的钙磷代谢紊乱、代谢性酸中毒,早期纠正高P T H血症,对于预防慢性肾衰竭患者心血管并发症的发生,降低病死率有重要意义。
出处 《中国乡村医药》 2014年第11期59-61,共3页
  • 相关文献

参考文献7

  • 1Fukagawa M,Kazama J J,Kurokawa K.Renal osteodystrophy and secondary hyperparathyroidism[J].Nephrol Dial Transplant,2002,17(suppl 10):2.
  • 2Kovacic V,Roguljic L,Kovacic V.Metabolic acidosis of chronically hemodialyzed patients[J].Am J Nephrol,2003,23(3):158.
  • 3Cirillo M.Rationale,pros and cons of GFR estimation:the Cockcroft-Gault and MDRD equations[J].G Ital Nefrol,2009,26(3):310.
  • 4Goodman WG,Goldin J,Kuizon BD,et al.Coronaryartery calcification in young adults with end-stage renal disease who are undergoing dialysis[J].N Engl J Med,2000,342(20):1478.
  • 5Block GA,Port FK.Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients:recommendations for a change in management[J].Am J Kidney Dis,2000,35(6):1226.
  • 6孙鲁英,王梅,杨莉.终末期肾脏病患者钙磷代谢及甲状旁腺激素水平的临床分析[J].北京大学学报(医学版),2005,37(2):147-150. 被引量:63
  • 7Cunningham J,Locatelli F,Rodriguez M.Secondary hyperparathyroidism:pathogenesis,disease progression,and therapeutic options[J].Clin J Am Soc Nephrol,2011,6(4):913.

二级参考文献18

  • 1Lemann JJ, Litzow JR, Lennon EJ. The effect of chronic acid loads in normal man: Further evidence against chronic metabolic acidosis[J]. J Clin Invest, 1966, 45:1608-1614
  • 2Lemann JJ, Litzow JR, Lennon EJ. Studies of the mechanism by which chronic metabolic acidosis augment urinary calcium excretion in man[J]. J Clin Invest, 1967, 46:1318-1328
  • 3Craig BL. Calcitriol metabolism during chronic metabolic acidosis[J]. Semin Nephrol, 1989, 9:65-71
  • 4Kurz P, Monier Faugere MC, Bognar B, et al. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease[J]. Kidney Int, 1994, 46:855-861
  • 5Nakano Y, Oshima T, Sasaki S, et al. Vitamin D receptor gene polymorphism is associated with serum total and ionized calcium concentration[J]. J Mol Med, 2000, 78:575-579
  • 6Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calciumХphosphorus product with mortality risk in chronic hemodialysis patients: a national study[J]. Am J Kidney Dis, 1998, 31: 607-617
  • 7Amann K, Gross ML, London GM, et al. Hyperphosphataemia-a silent killer of patients with renal failure[J]? Nephrol Dial Transplant, 1999, 14:2085-2087
  • 8Brenner BM. The Kidney[M]. 北京: 科学出版社,2001. 520-556
  • 9Goldfarb S. Renal osteodystrophy, disorders of divalent ion metabolism, and nephrolithiasis[J]. Nephrology Self-Assessment Program, 2002, 1: 55-68
  • 10Cannata-Andia JB. Pathogenesis, prevention and management of low-bone turnover[J]. Nephrol Dial Transplant, 2000, 15(Suppl 5): 15-17

共引文献62

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部